Stakeholder Preference Studies

Evaluate the preferences of patients, HCPs, caregivers and payers to demonstrate product value.

Generate clear evidence on benefit-risk trade-offs

Get a deeper understanding of patients’ tolerance for risk and their perspectives on benefit.

Customize for your needs with multidisciplinary teams

Our approach is customized to suit you, with expertise in advanced methods, statistics, and health outcomes research.

Reach the right stakeholders

Get global access to patients, physicians, nurses and others with local expertise, thanks to our precise recruitment approach.

Trust a peer-reviewed, published partner

We have published preference research, including formative qualitative research, for a wide range of health conditions.

The US Food and Drug Administration (FDA) and European Medicines Agency (EMA) are increasing their focus on patient preference in regulatory submission packages. Kantar will recommend the optimal stated preference methodology, e.g. discrete choice experiment (DCE), best-worst scaling (BWS), etc., to meet your research objectives throughout the product lifecycle. We will also apply our global recruiting capabilities to ensure recruitment with the right degree of precision.